Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 451

1.

Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7.

Koide N, Naiki Y, Morikawa A, Tumurkhuu G, Dagvadorj J, Noman AS, Iftekar-E-Khuda I, Komatsu T, Yoshida T, Yokochi T.

Microbiol Immunol. 2009 May;53(5):295-300. doi: 10.1111/j.1348-0421.2009.00118.x. Epub 2009 Feb 4.

2.

Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice.

Noman AS, Koide N, Khuda II, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

FEMS Immunol Med Microbiol. 2009 Aug;56(3):204-11. doi: 10.1111/j.1574-695X.2009.00567.x. Epub 2009 May 6.

3.

Gamma interferon-induced nitric oxide production in mouse CD5+ B1-like cell line and its association with apoptotic cell death.

Koide N, Sugiyama T, Mu MM, Mori I, Yoshida T, Hamano T, Yokochi T.

Microbiol Immunol. 2003;47(9):669-79.

4.
5.

The enhancing action of D-galactosamine on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells.

Morikawa A, Koide N, Sugiyama T, Mu MM, Hassan F, Islam S, Ito H, Mori I, Yoshida T, Yokochi T.

FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):211-8.

6.

Flavopiridol inhibits lipopolysaccharide-induced TNF-α production through inactivation of nuclear factor-κB and mitogen-activated protein kinases in the MyD88-dependent pathway.

Haque A, Koide N, Iftakhar-E-Khuda I, Noman AS, Odkhuu E, Badamtseren B, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Microbiol Immunol. 2011 Mar;55(3):160-7. doi: 10.1111/j.1348-0421.2010.00304.x.

7.

2-aminopurine inhibits lipopolysaccharide-induced nitric oxide production by preventing IFN-beta production.

Sugiyama T, Fujita M, Koide N, Mori I, Yoshida T, Mori H, Yokochi T.

Microbiol Immunol. 2004;48(12):957-63.

8.

The inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by Clostridium perfringens alpha-toxin and its relation to alpha-toxin-induced intracellular ceramide generation.

Tumurkhuu G, Koide N, Dagvadorj J, Noman AS, Iftakhar-E-Khuda I, Naiki Y, Komatsu T, Yoshida T, Oda M, Nagahama M, Sakurai J, Yokochi T.

Int J Med Microbiol. 2009 Dec;299(8):554-62. doi: 10.1016/j.ijmm.2009.04.003. Epub 2009 May 20. Erratum in: Int J Med Microbiol. 2015 May;305(3):433. Iftekar-E-Khuda, Imtiaz [corrected to Iftakhar-E-Khuda, Imtiaz].

PMID:
19467928
9.

A Toll-like receptor 2 ligand, Pam3CSK4, augments interferon-γ-induced nitric oxide production via a physical association between MyD88 and interferon-γ receptor in vascular endothelial cells.

Tsolmongyn B, Koide N, Jambalganiin U, Odkhuu E, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Immunology. 2013 Nov;140(3):352-61. doi: 10.1111/imm.12147.

10.

Inhibition of extracellular signal-regulated kinase 1/2 augments nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophage cells.

Koide N, Ito H, Mu MM, Sugiyama T, Hassan F, Islam S, Mori I, Yoshida T, Yokochi T.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):213-9.

11.

Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells.

Badamtseren B, Odkhuu E, Koide N, Haque A, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T.

Cell Immunol. 2011;270(1):19-24. doi: 10.1016/j.cellimm.2011.03.018. Epub 2011 Apr 7.

PMID:
21477797
12.

Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.

Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, Yoshida T, Yokochi T.

Microbiol Immunol. 2008 Dec;52(12):585-90. doi: 10.1111/j.1348-0421.2008.00076.x.

13.

MnTBAP, a synthetic metalloporphyrin, inhibits production of tumor necrosis factor-alpha in lipopolysaccharide-stimulated RAW 264.7 macrophages cells via inhibiting oxidative stress-mediating p38 and SAPK/JNK signaling.

Tumurkhuu G, Koide N, Dagvadorj J, Hassan F, Islam S, Naiki Y, Mori I, Yoshida T, Yokochi T.

FEMS Immunol Med Microbiol. 2007 Mar;49(2):304-11. Epub 2007 Jan 10.

14.

B1 cells produce nitric oxide in response to a series of toll-like receptor ligands.

Tumurkhuu G, Koide N, Dagvadorj J, Noman AS, Khuda II, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Cell Immunol. 2010;261(2):122-7. doi: 10.1016/j.cellimm.2009.11.009. Epub 2009 Dec 3.

PMID:
20036355
15.
16.

Seladin-1 is a novel lipopolysaccharide (LPS)-responsive gene and inhibits the tumour necrosis factor-alpha production and osteoclast formation in response to LPS.

Khuda II, Koide N, Noman AS, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Immunology. 2010 Sep;131(1):59-66. doi: 10.1111/j.1365-2567.2010.03274.x. Epub 2010 Apr 6.

17.

Novel mechanism of U18666A-induced tumour necrosis factor-alpha production in RAW 264.7 macrophage cells.

Iftakhar-E-Khuda I, Koide N, Hassan F, Noman AS, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Clin Exp Immunol. 2009 Mar;155(3):552-8. doi: 10.1111/j.1365-2249.2008.03779.x.

18.

Retinoblastoma protein-interacting zinc finger 1, a tumor suppressor, augments lipopolysaccharide-induced proinflammatory cytokine production via enhancing nuclear factor-kappaB activation.

Noman AS, Koide N, Iftakhar-E-Khuda I, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Cell Immunol. 2010;264(2):114-8. doi: 10.1016/j.cellimm.2010.05.007. Epub 2010 May 27.

PMID:
20557878
19.

Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells.

Hassan F, Islam S, Tumurkhuu G, Dagvadorj J, Naiki Y, Komatsu T, Koide N, Yoshida T, Yokochi T.

Cell Immunol. 2009;256(1-2):99-103. doi: 10.1016/j.cellimm.2009.01.013. Epub 2009 Feb 28.

PMID:
19251253
20.

5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-kappaB activation.

Islam S, Hassan F, Tumurkhuu G, Ito H, Koide N, Mori I, Yoshida T, Yokochi T.

Cancer Chemother Pharmacol. 2007 Feb;59(2):227-33. Epub 2006 May 25.

PMID:
16724238

Supplemental Content

Support Center